Prevalence and clinical relevance of systematically tested antimitochondrial antibodies in systemic sclerosis

Immuno-based profiling of knee osteoarthritis patients identifies baseline characteristics associated with positive response to autologous platelet-rich plasma injection at one-year follow-up.

Frontiers in immunology·2026

Macrophage activation syndrome in systemic lupus erythematosus and Still's disease: distinct phenotypes shaped by the underlying diseases.

Rheumatology (Oxford, England)·2026

The placebo effect in psoriatic arthritis.

Autoimmunity reviews·2026

Cancer in Systemic Sclerosis: Clinical Associations and Prognostic Impact From the EUSTAR Registry.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Minimal residual disease flow cytometry of peripheral blood B-cell subsets in patients with idiopathic inflammatory myopathies following rituximab therapy: a single-centre, retrospective cohort study.

The Lancet. Rheumatology·2026

High-sensitivity flow cytometry in rheumatoid arthritis shows that early B-cell subset depletion is linked to 5-year rituximab response, while failure to deplete B cells occurs early in subsequent poly-refractory disease.

Annals of the rheumatic diseases·2026

Differential regulation of SOCS signalling and immunoproteasome pathways by JAK inhibitors and TNF inhibitors in rheumatoid arthritis.

Arthritis research & therapy·2026

Macrovascular damage in polymyalgia rheumatica: integrated vascular phenotyping in the POLYMYACARD cohort.

Arthritis research & therapy·2026

Allogeneic CD19 CAR-NK cell therapy for a patient with relapsed and refractory lupus nephritis.

Arthritis research & therapy·2026

Elevated pro-BNP and low-grade inflammation are associated with low bone mineral density in systemic sclerosis, a case control study.

Arthritis research & therapy·2026

Early risk stratification in lupus nephritis based on established prognostic factors: association with outcomes under triple therapy.

Arthritis research & therapy·2026

Inflammation-driven bone erosion and reactive remodeling in experimental arthritis revealed by cortical bone surface analysis.

Arthritis research & therapy·2026

Impaired regulatory T cell mediated immune tolerance promotes neurodegeneration in glaucoma.

medRxiv : the preprint server for health sciences·2026

Establishment of a novel lupus mesenteric vasculitis mouse model and exploration of its exacerbation mechanisms.

Frontiers in immunology·2026

A mouse model of myotonic dystrophy type 1 exhibits pain-like behavior and peripheral nociceptor hyperexcitability.

bioRxiv : the preprint server for biology·2026

Idiopathic axillary web syndrome as a rare cause of shoulder pain: A case report.

Turkish journal of physical medicine and rehabilitation·2026

Clinical features of concurrent systemic lupus erythematosus and renal biopsy-proven antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective analysis.

Frontiers in medicine·2026

Sustained clinical stability with telitacicept-containing maintenance therapy following glucocorticoid and IVIG induction for lupus enteritis with autoimmune hemolytic anemia: a case report.

Frontiers in immunology·2026

Related Experiment Videos

Prevalence and clinical relevance of systematically tested antimitochondrial antibodies in systemic sclerosis

Related Concept Videos

Immuno-based profiling of knee osteoarthritis patients identifies baseline characteristics associated with positive response to autologous platelet-rich plasma injection at one-year follow-up.

Macrophage activation syndrome in systemic lupus erythematosus and Still's disease: distinct phenotypes shaped by the underlying diseases.

The placebo effect in psoriatic arthritis.

Cancer in Systemic Sclerosis: Clinical Associations and Prognostic Impact From the EUSTAR Registry.

Minimal residual disease flow cytometry of peripheral blood B-cell subsets in patients with idiopathic inflammatory myopathies following rituximab therapy: a single-centre, retrospective cohort study.

High-sensitivity flow cytometry in rheumatoid arthritis shows that early B-cell subset depletion is linked to 5-year rituximab response, while failure to deplete B cells occurs early in subsequent poly-refractory disease.

Differential regulation of SOCS signalling and immunoproteasome pathways by JAK inhibitors and TNF inhibitors in rheumatoid arthritis.

Macrovascular damage in polymyalgia rheumatica: integrated vascular phenotyping in the POLYMYACARD cohort.

Allogeneic CD19 CAR-NK cell therapy for a patient with relapsed and refractory lupus nephritis.

Elevated pro-BNP and low-grade inflammation are associated with low bone mineral density in systemic sclerosis, a case control study.

Early risk stratification in lupus nephritis based on established prognostic factors: association with outcomes under triple therapy.

Inflammation-driven bone erosion and reactive remodeling in experimental arthritis revealed by cortical bone surface analysis.

Impaired regulatory T cell mediated immune tolerance promotes neurodegeneration in glaucoma.

Establishment of a novel lupus mesenteric vasculitis mouse model and exploration of its exacerbation mechanisms.

A mouse model of myotonic dystrophy type 1 exhibits pain-like behavior and peripheral nociceptor hyperexcitability.

Idiopathic axillary web syndrome as a rare cause of shoulder pain: A case report.

Clinical features of concurrent systemic lupus erythematosus and renal biopsy-proven antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective analysis.

Sustained clinical stability with telitacicept-containing maintenance therapy following glucocorticoid and IVIG induction for lupus enteritis with autoimmune hemolytic anemia: a case report.

Related Experiment Videos

Prevalence and clinical relevance of systematically tested antimitochondrial antibodies in systemic sclerosis

Related Concept Videos

Related Articles